• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗南部 COVID-19 疫情暴发前后结核病发病率和临床特征的变化。

Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.

机构信息

Thoracic and Vascular Surgery Research Center, Shiraz University of Medical Science, Shiraz, Iran.

Department of Internal Medicine, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

BMC Infect Dis. 2024 Sep 27;24(1):1043. doi: 10.1186/s12879-024-09947-0.

DOI:10.1186/s12879-024-09947-0
PMID:39333984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11430532/
Abstract

INTRODUCTION

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a significant global health threat. It results in substantial mortality and may be underrecognized due to insufficient screening and diagnostic challenges. Furthermore, TB's impact is closely linked to complex socioeconomic and healthcare factors. The COVID-19 pandemic has exacerbated these challenges due to similarities in clinical presentation and transmission dynamics with TB. Socioeconomic factors such as limited access to healthcare services, resource constraints, and social stigma further complicate TB management. Historically, TB faced increased burdens during natural disasters, wars, and pandemics. This study analyzes TB incidence changes, emphasizing the crucial need for timely diagnosis within the context of COVID-19 measures.

METHOD

This cross-sectional study, conducted at Shiraz's TB referral center in Southern Iran, covered the period from January 1, 2018, to December 31, 2022. We analyzed patient data, including epidemiological and demographic factors, clinical and radiological features, and treatment outcomes. Data were compared between the pre-COVID-19 pandemic era and the COVID-19 pandemic era (from March 2020), using standard and regression analyses. A P-value of less than 0.05 was considered statistically significant.

RESULTS

We analyzed 388 TB patients with a mean age of 48.38 ± 20.53 years, including 264 pulmonary cases (68.0%). The highest incidence of TB was recorded in 2019, representing 27.6% of the cases. During the COVID-19 era, logistic regression analysis identified significant associations with higher education levels (P = 0.032; OR = 1.380; 95% CI: 1.028-1.851), a decrease in symptoms such as sputum production (P = 0.004; OR = 0.342; 95% CI: 0.166-0.705) and chills (P = 0.036; OR = 0.282; 95% CI: 0.087-0.919), and an increase in symptoms of fatigue (P = 0.006; OR = 2.856; 95% CI: 1.358-6.005).

CONCLUSION

The COVID-19 pandemic has had a prolonged impact on TB cases in our country, resulting in a reduction in reported cases due to challenges in quarantine and screening. However, it has also led to a shift in TB patterns and a potential increase in latent TB cases and future mortality rates. Addressing the repercussions requires enhanced control strategies, prioritized service delivery, and secured funding for intensified case finding, expanded contact-tracing, community engagement, digital health tools, and uninterrupted access to medications.

摘要

简介

结核病(TB)是由结核分枝杆菌引起的,仍然是全球重大的健康威胁。它导致大量死亡,由于筛查和诊断方面的不足,可能被低估。此外,结核病的影响与复杂的社会经济和医疗保健因素密切相关。由于 COVID-19 在临床表现和传播动力学方面与结核病相似,COVID-19 大流行加剧了这些挑战。社会经济因素,如获得医疗服务的机会有限、资源限制和社会耻辱感,进一步使结核病的管理复杂化。历史上,结核病在自然灾害、战争和大流行期间面临更大的负担。本研究分析了结核病发病率的变化,强调了在 COVID-19 措施背景下及时诊断的迫切需要。

方法

本横断面研究在伊朗南部设拉子的结核病转诊中心进行,时间范围为 2018 年 1 月 1 日至 2022 年 12 月 31 日。我们分析了患者的流行病学和人口统计学因素、临床和放射学特征以及治疗结果等数据。使用标准和回归分析比较了 COVID-19 大流行前时代和 COVID-19 大流行时代(2020 年 3 月起)的数据。P 值小于 0.05 被认为具有统计学意义。

结果

我们分析了 388 名结核病患者,平均年龄为 48.38±20.53 岁,包括 264 例肺部病例(68.0%)。结核病发病率最高的年份是 2019 年,占病例的 27.6%。在 COVID-19 时代,逻辑回归分析发现与较高教育水平显著相关(P=0.032;OR=1.380;95%CI:1.028-1.851),与痰液产生(P=0.004;OR=0.342;95%CI:0.166-0.705)和寒战(P=0.036;OR=0.282;95%CI:0.087-0.919)等症状减少以及疲劳(P=0.006;OR=2.856;95%CI:1.358-6.005)等症状增加相关。

结论

COVID-19 大流行对我国结核病病例产生了持久影响,由于检疫和筛查方面的挑战,导致报告病例减少。然而,它也导致了结核病模式的转变,潜在地增加了潜伏性结核病病例和未来的死亡率。应对这些影响需要加强控制策略,优先提供服务,并确保获得资金,以加强病例发现、扩大接触者追踪、社区参与、数字健康工具和不间断获得药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/11430532/f7a0f4d7d825/12879_2024_9947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/11430532/f7a0f4d7d825/12879_2024_9947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f62e/11430532/f7a0f4d7d825/12879_2024_9947_Fig1_HTML.jpg

相似文献

1
Changes in incidence and clinical features of tuberculosis with regard to the COVID-19 outbreak in Southern Iran.伊朗南部 COVID-19 疫情暴发前后结核病发病率和临床特征的变化。
BMC Infect Dis. 2024 Sep 27;24(1):1043. doi: 10.1186/s12879-024-09947-0.
2
Assessing the impact of COVID-19 on tuberculosis detection and treatment in healthcare facilities across Addis Ababa, Ethiopia: A comprehensive mixed-method, multi-center study.评估 COVID-19 对埃塞俄比亚亚的斯亚贝巴各医疗机构结核病检测和治疗的影响:一项综合的混合方法、多中心研究。
PLoS One. 2024 Oct 3;19(10):e0311408. doi: 10.1371/journal.pone.0311408. eCollection 2024.
3
Burden of COVID-19 pandemic on tuberculosis hospitalisation patterns at a tertiary care hospital in Rajasthan, India: a retrospective analysis.印度拉贾斯坦邦一家三级护理医院中 COVID-19 大流行对结核病住院模式的影响:一项回顾性分析
BMJ Open. 2024 May 3;14(5):e080623. doi: 10.1136/bmjopen-2023-080623.
4
Effect of COVID-19 pandemic on incidence of mycobacterial diseases among suspected tuberculosis pulmonary patients in Tehran, Iran.伊朗德黑兰疑似肺结核患者中 COVID-19 大流行对分枝杆菌病发病率的影响。
Int J Mycobacteriol. 2022 Oct-Dec;11(4):415-422. doi: 10.4103/ijmy.ijmy_167_22.
5
Social-behavioral insights in understanding tuberculosis transmission pattern during the COVID-19 pandemic period in Kuala Lumpur, Malaysia: The MyTBNet study protocol.马来西亚吉隆坡在 COVID-19 大流行期间理解结核病传播模式的社会行为学见解:MyTBNet 研究方案。
PLoS One. 2024 Sep 26;19(9):e0307921. doi: 10.1371/journal.pone.0307921. eCollection 2024.
6
Changes in the incidence, clinical features and outcomes of tuberculosis during COVID-19 pandemic.在 COVID-19 大流行期间,结核病的发病率、临床特征和结局的变化。
J Infect Public Health. 2024 Sep;17(9):102511. doi: 10.1016/j.jiph.2024.102511. Epub 2024 Jul 25.
7
"I pity the TB patient": a mixed methods study assessing the impact of the COVID-19 pandemic on TB services in two major Indonesian cities and distilling lessons for the future.“我同情结核病患者”:一项混合方法研究,评估了 COVID-19 大流行对印度尼西亚两个主要城市结核病服务的影响,并为未来总结了经验教训。
BMJ Glob Health. 2024 May 16;9(5):e014943. doi: 10.1136/bmjgh-2023-014943.
8
First case series and literature review of coronavirus disease 2019 (COVID-19) associated pulmonary tuberculosis in Southeast Asia: Challenges and opportunities.东南亚 2019 冠状病毒病(COVID-19)相关肺结核的首例病例系列和文献综述:挑战与机遇。
J Infect Public Health. 2023 Jan;16(1):80-89. doi: 10.1016/j.jiph.2022.11.029. Epub 2022 Nov 29.
9
Exploring the perspectives of members of international tuberculosis control and research networks on the impact of COVID-19 on tuberculosis services: a cross sectional survey.探索国际结核病控制和研究网络成员对 COVID-19 对结核病服务影响的看法:一项横断面调查。
BMC Health Serv Res. 2021 Aug 12;21(1):798. doi: 10.1186/s12913-021-06852-z.
10
Tuberculosis结核病

引用本文的文献

1
Nuances in the global impact of COVID-19 on tuberculosis control efforts: An updated review.新冠疫情对结核病防控工作全球影响的细微差别:最新综述
Medicine (Baltimore). 2025 Apr 18;104(16):e42195. doi: 10.1097/MD.0000000000042195.
2
Epidemiological and Antimicrobial Resistance Trends in Bacterial Keratitis: A Hospital-Based 10-Year Study (2014-2024).细菌性角膜炎的流行病学及抗菌药物耐药性趋势:一项基于医院的10年研究(2014 - 2024年)
Microorganisms. 2025 Mar 17;13(3):670. doi: 10.3390/microorganisms13030670.

本文引用的文献

1
The Pattern of Tuberculosis in Iran: A National Cross-Sectional Study.伊朗的结核病模式:一项全国性横断面研究。
Iran J Public Health. 2023 Jan;52(1):193-200. doi: 10.18502/ijph.v52i1.11682.
2
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions.结核病和 COVID-19 大流行的交织:人群层面和患者层面的影响、临床表现和纠正干预措施。
Lancet Respir Med. 2022 Jun;10(6):603-622. doi: 10.1016/S2213-2600(22)00092-3. Epub 2022 Mar 23.
3
Vax the world.
为世界接种疫苗。
Science. 2021 Nov 26;374(6571):1031. doi: 10.1126/science.abn3081. Epub 2021 Nov 25.
4
Tuberculosis and COVID-19 co-infection: description of the global cohort.结核病和 COVID-19 合并感染:全球队列描述。
Eur Respir J. 2022 Mar 24;59(3). doi: 10.1183/13993003.02538-2021. Print 2022 Mar.
5
Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study.评估 COVID-19 大流行对结核病服务的影响:一项全球研究。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01786-2021. Print 2021 Nov.
6
Diagnosis of COVID-19: Considerations, controversies and challenges.2019冠状病毒病的诊断:考量、争议与挑战
Afr J Thorac Crit Care Med. 2020 Apr 21;26(2). doi: 10.7196/AJTCCM.2020.v26i2.099. eCollection 2020.
7
Spatio-temporal epidemiology of the tuberculosis incidence rate in Iran 2008 to 2018.2008 年至 2018 年伊朗结核病发病率的时空流行病学。
BMC Public Health. 2021 Jun 7;21(1):1093. doi: 10.1186/s12889-021-11157-1.
8
The impact of COVID-19 on TB: a review of the data.COVID-19 对结核病的影响:数据回顾。
Int J Tuberc Lung Dis. 2021 Jun 1;25(6):436-446. doi: 10.5588/ijtld.21.0148.
9
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects.结核病与 COVID-19 的相互作用:生物学、临床和公共卫生影响的综述。
Pulmonology. 2021 Mar-Apr;27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012. Epub 2021 Jan 22.
10
Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.《结核病及其在新冠疫情时代的未来:2021年肺病学系列》
Pulmonology. 2021 Mar-Apr;27(2):94-96. doi: 10.1016/j.pulmoe.2020.10.005. Epub 2020 Nov 17.